  See all
 |
Articles: Cardiac/Hypertension |
Prior Articles
Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals
Expert Opinion on Investigational Drugs, 12/01/09
Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09
Free full text
Multaq Approved in the European Union for Patients with Atrial Fibrillation
Sanofi-aventis, 12/01/09
Free full text
Vernakalant hydrochloride for the treatment of atrial fibrillation
Expert Opinion on Investigational Drugs, 11/30/09 The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Vascular Health and Risk Management, 11/30/09
Free full text
Revew Article
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09 Major European regulatory milestone in cardiovascular protection for Micardis : Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
Boehringer Ingelheim, 11/30/09
Free full text
Beta-Adrenergic Antagonists in Hypertension: A Review of the Evidence
Annals of Pharmacotherapy, 11/25/09 Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09 The role of pulmonary veins in atrial fibrillation
Pharmacology & Therapeutics, 11/24/09 Telmisartan prevents cardiovascular events in a broad group of at-risk patients
Expert Opinion in Pharmacotherapy, 11/23/09 Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events
European Heart Journal, 11/23/09 Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09 Pharmacogenetic profiling in the treatment of heart disease
Translational Research, The Journal of Laboratory and Clinical Medicine, 11/20/09 Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09 Sub-lethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low pro-senescent doses of epirubicin: the protective role of dexrazoxane
Journal of Pharmacology and Experimental Therapeutics, 11/20/09 The D5 dopamine receptor mediates BKCa channel activation in human coronary artery smooth muscle cells
Journal of Pharmacology and Experimental Therapeutics, 11/20/09 Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia
Resuscitation, 11/18/09 Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
Pediatric Cardiology, 11/18/09 The Impact of Ezetimibe on Endothelial Function and Other Markers of Cardiovascular Risk
Annals of Pharmacotherapy, 11/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
